Application of population screening principles to genetic screening for adult-onset conditions

Wylie Burke, Steven Scott Coughlin, Nancy C. Lee, Douglas L. Weed, Muin J. Khoury

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Recent advances in molecular genetics have highlighted the potential use of genetic testing to screen for adult-onset chronic diseases. Several issues must be addressed, however, before such tests can be recommended for population-based prevention programs. These issues include the adequacy of the scientific evidence, the balance of risks and benefits, the need for counseling and informed consent, and the costs and resources required. Ongoing assessment of the screening program and quality assurance of laboratory testing are also needed. This paper considers the application of general principles for mass screening to genetic testing for susceptibility to adult-onset chronic diseases. Evaluation of proposals for genetic screening in context of these principles reveals that needed evidence is often absent, particularly with respect to the predictive value of tests, efficacy of interventions, and social consequences of testing. The principles of population screening are developed into a framework for public health policy on genetic screening that has three stages: assessment of the screening test and interventions for those who test positive, including assessment of risks and costs, policy development, and program evaluation. Essential elements are identified, including evaluation of evidence and processes for consensus development and program evaluation. The proposed framework for public health policy-making outlined in this commentary, when combined with future efforts that involve an authoritative consensus process, may be useful for the evaluation and planning of genetic screening programs aimed at reducing morbidity and mortality from adult-onset chronic diseases.

Original languageEnglish (US)
Pages (from-to)201-211
Number of pages11
JournalGenetic Testing
Volume5
Issue number3
DOIs
StatePublished - Sep 1 2001

Fingerprint

Genetic Testing
Chronic Disease
Population
Policy Making
Program Evaluation
Public Policy
Health Policy
Consensus
Public Health
Predictive Value of Tests
Costs and Cost Analysis
Mass Screening
Genetic Predisposition to Disease
Informed Consent
Counseling
Molecular Biology
Morbidity
Mortality

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Application of population screening principles to genetic screening for adult-onset conditions. / Burke, Wylie; Coughlin, Steven Scott; Lee, Nancy C.; Weed, Douglas L.; Khoury, Muin J.

In: Genetic Testing, Vol. 5, No. 3, 01.09.2001, p. 201-211.

Research output: Contribution to journalArticle

Burke, Wylie ; Coughlin, Steven Scott ; Lee, Nancy C. ; Weed, Douglas L. ; Khoury, Muin J. / Application of population screening principles to genetic screening for adult-onset conditions. In: Genetic Testing. 2001 ; Vol. 5, No. 3. pp. 201-211.
@article{e1835b8b9c9a4c95a6d64934dfb8fa88,
title = "Application of population screening principles to genetic screening for adult-onset conditions",
abstract = "Recent advances in molecular genetics have highlighted the potential use of genetic testing to screen for adult-onset chronic diseases. Several issues must be addressed, however, before such tests can be recommended for population-based prevention programs. These issues include the adequacy of the scientific evidence, the balance of risks and benefits, the need for counseling and informed consent, and the costs and resources required. Ongoing assessment of the screening program and quality assurance of laboratory testing are also needed. This paper considers the application of general principles for mass screening to genetic testing for susceptibility to adult-onset chronic diseases. Evaluation of proposals for genetic screening in context of these principles reveals that needed evidence is often absent, particularly with respect to the predictive value of tests, efficacy of interventions, and social consequences of testing. The principles of population screening are developed into a framework for public health policy on genetic screening that has three stages: assessment of the screening test and interventions for those who test positive, including assessment of risks and costs, policy development, and program evaluation. Essential elements are identified, including evaluation of evidence and processes for consensus development and program evaluation. The proposed framework for public health policy-making outlined in this commentary, when combined with future efforts that involve an authoritative consensus process, may be useful for the evaluation and planning of genetic screening programs aimed at reducing morbidity and mortality from adult-onset chronic diseases.",
author = "Wylie Burke and Coughlin, {Steven Scott} and Lee, {Nancy C.} and Weed, {Douglas L.} and Khoury, {Muin J.}",
year = "2001",
month = "9",
day = "1",
doi = "10.1089/10906570152742245",
language = "English (US)",
volume = "5",
pages = "201--211",
journal = "Genetic Testing and Molecular Biomarkers",
issn = "1945-0265",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Application of population screening principles to genetic screening for adult-onset conditions

AU - Burke, Wylie

AU - Coughlin, Steven Scott

AU - Lee, Nancy C.

AU - Weed, Douglas L.

AU - Khoury, Muin J.

PY - 2001/9/1

Y1 - 2001/9/1

N2 - Recent advances in molecular genetics have highlighted the potential use of genetic testing to screen for adult-onset chronic diseases. Several issues must be addressed, however, before such tests can be recommended for population-based prevention programs. These issues include the adequacy of the scientific evidence, the balance of risks and benefits, the need for counseling and informed consent, and the costs and resources required. Ongoing assessment of the screening program and quality assurance of laboratory testing are also needed. This paper considers the application of general principles for mass screening to genetic testing for susceptibility to adult-onset chronic diseases. Evaluation of proposals for genetic screening in context of these principles reveals that needed evidence is often absent, particularly with respect to the predictive value of tests, efficacy of interventions, and social consequences of testing. The principles of population screening are developed into a framework for public health policy on genetic screening that has three stages: assessment of the screening test and interventions for those who test positive, including assessment of risks and costs, policy development, and program evaluation. Essential elements are identified, including evaluation of evidence and processes for consensus development and program evaluation. The proposed framework for public health policy-making outlined in this commentary, when combined with future efforts that involve an authoritative consensus process, may be useful for the evaluation and planning of genetic screening programs aimed at reducing morbidity and mortality from adult-onset chronic diseases.

AB - Recent advances in molecular genetics have highlighted the potential use of genetic testing to screen for adult-onset chronic diseases. Several issues must be addressed, however, before such tests can be recommended for population-based prevention programs. These issues include the adequacy of the scientific evidence, the balance of risks and benefits, the need for counseling and informed consent, and the costs and resources required. Ongoing assessment of the screening program and quality assurance of laboratory testing are also needed. This paper considers the application of general principles for mass screening to genetic testing for susceptibility to adult-onset chronic diseases. Evaluation of proposals for genetic screening in context of these principles reveals that needed evidence is often absent, particularly with respect to the predictive value of tests, efficacy of interventions, and social consequences of testing. The principles of population screening are developed into a framework for public health policy on genetic screening that has three stages: assessment of the screening test and interventions for those who test positive, including assessment of risks and costs, policy development, and program evaluation. Essential elements are identified, including evaluation of evidence and processes for consensus development and program evaluation. The proposed framework for public health policy-making outlined in this commentary, when combined with future efforts that involve an authoritative consensus process, may be useful for the evaluation and planning of genetic screening programs aimed at reducing morbidity and mortality from adult-onset chronic diseases.

UR - http://www.scopus.com/inward/record.url?scp=0035693005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035693005&partnerID=8YFLogxK

U2 - 10.1089/10906570152742245

DO - 10.1089/10906570152742245

M3 - Article

VL - 5

SP - 201

EP - 211

JO - Genetic Testing and Molecular Biomarkers

JF - Genetic Testing and Molecular Biomarkers

SN - 1945-0265

IS - 3

ER -